Latest Memorial Sloan–Kettering Cancer Center Stories
Event Raises Over $275,000 for Cancer and AIDS Research NEW YORK, June 7, 2011 /PRNewswire-USNewswire/ -- The T.J. Martell Foundation is proud to announce that it raised over $275,000 at its 12th Annual Family Day honoring Big Time Rush on June 5, 2011 at Roseland Ballroom in New York City.
The Society for Translational Oncology (STO) is honored to award the 2011 Bob Pinedo Cancer Care Prize to Dr. Gabriel N. Hortobágyi, Nellie B. Connally Chair, Breast Medical Oncology, The University of Texas MD Anderson Cancer Center. Dr.
FAIRFIELD, Conn., April 15, 2011 /PRNewswire/ -- Beginning today through July 14, Stop & Shop customers will have the opportunity to help support pediatric cancer at Memorial Sloan-Kettering Cancer Center through Stop & Shop's annual Triple Winner GameÂ®.
Researchers at Memorial Sloan-Kettering Cancer Center have found that change in PSA levels over time â€” known as PSA velocity â€” is a poor predictor of prostate cancer and may lead to many unnecessary biopsies.
The Max Cure Foundation/Samuel Waxman Cancer Research Foundation Collaborative Grant in Pediatric Cancer Research will fund novel research to develop minimally toxic therapies to improve the quality of life for children with cancer, with the ultimate goal of finding cures for pediatric cancers.
NEW YORK, Jan. 11, 2011 /PRNewswire-USNewswire/ -- Peter Quinn, CEO of the T.J. Martell Foundation, is pleased to announce the 2011 cancer and AIDS research grant recipients.
A study published in the December issue of The Journal of Nuclear Medicine identified positron emission tomography/computed tomography (PET/CT) scans as a potentially useful tool for predicting local recurrence in lung cancer patients treated with radiofrequency ablation (RFA).
There is new hope for people with acute myelogenous leukemia (AML), a fast-growing cancer of the blood and bone marrow.
Because primary lung adenocarcinoma is exceedingly rare in the pediatric population, it is difficult to properly classify certain lung tumors in children and adolescents.
An international study led by researchers at Memorial Sloan-Kettering Cancer Center has identified genetic variants in women with BRCA2 mutations that may increase or decrease their risk of developing breast cancer.